Distribution volumes of macromolecules in human ovarian and endometrial cancers—effects of extracellular matrix structure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 1, 2015, Pages H18-H28

  Haslene Hox, Hanne ^a,c   Ovel, Eystein ^a   Woie, Kathrine ^b   Salvesen, Helga B ^a,b   Tenstad, Olav ^a   Wiig, Helge ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c SINTEF MATERIALS AND CHEMISTRY   (Norway)

Author keywords

Endometrial cancer; Extracellular matrix; Interstitial fluid; Interstitium; Microenvironment; Ovarian cancer; Proteomics

Indexed keywords

ALBUMIN; COLLAGEN; PLASMA PROTEIN; ALB PROTEIN, HUMAN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; SERUM ALBUMIN; WATER;

AGED; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL FLUID; MACROMOLECULE; MASS SPECTROMETRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; VOLUME OF DISTRIBUTION; BLOOD; CASE CONTROL STUDY; CHEMISTRY; ENDOMETRIUM TUMOR; EXTRACELLULAR FLUID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; MOLECULAR WEIGHT; OVARY TUMOR; PATHOLOGY; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MICROENVIRONMENT;

AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; ENDOMETRIAL NEOPLASMS; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; MIDDLE AGED; MOLECULAR WEIGHT; OVARIAN NEOPLASMS; PROTEOMICS; SERUM ALBUMIN; TANDEM MASS SPECTROMETRY; TUMOR MICROENVIRONMENT; WATER;

EID: 84925229927     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00672.2014     Document Type: Article

References (52)

1. Aukland K, Tenstad O, Wiig H. Distribution spaces for hyaluronan and albumin in rat tail tendons. Am J PhysioI Heart Circ Physiol 281: H1589-H1597, 2001.
2. Behrendt N. Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variants. Mol Immunol 22: 1005-1008, 1985.
3. Bernard N, Lombart C, Waks M. Miklitication of rat hemopexin properties upon heme binding. Eur J Biochem 103: 271-276, 1980.
4. Bert JL, Pearce RH, Mathieson JM, Warner SJ. Characterization of collagenous meshworks by volume exclusion of dextrans. Biochem J 191: 761-768, 1980.
5. Bertolatus JA, Abuyousef M, Hunsicker LG. Glomerular sieving of high molecular weight proteins in proteinuric rats. Kidney Int 31: 1257- 1266, 1987.
6. Bokisch VA, Dierich MP, Muiler-Eberhard HJ. Third component of complement (C3): structural properties in relation to functions. Proc Nall Acad Sci USA 72: 1989-1993, 1975.
7. Butcher DT, Ailiston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 9: 108-122, 2009.
8. Choi J, Credit K, Henderson K, Deverkadra R, He Z, Wiig H, Vanpelt H, Flessncr MF. Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration. Clin Cancer Res 12: 1906-1912, 2006.
9. Cortesi L, Rossi E, Della Casa L, Barchetti A, Nicoli A, Piana S, Abrate M, La Sala GB, Federico M, Iannanc A. Protein expression patterns associated with advanced stage ovarian cancer. Electrophoresis 32: 1992-2003, 2011.
10. Gao Y, Yue W, Zhang P, Li L, Xie X, Yuan H, Chen L, Liu D, Yan F, Pei X. Spindlinl, a novel nuclear protein with a role in the transformation of NIH3T3 cells. Biochem Biophys Res Commun 335: 343-350, 2005.
11. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91: 1071-1121, 2011.
12. Gromov P, Gromova I, Olsen CJ, Timmermans-Wiclenga V, Talman ML, Serizawa RR, Moreira JM. Tumor interstitial fluid-a treasure trove of cancer biomarkers. Biochim Biophys Acta 1834: 2259-2270, 2013.
13. Guo J, Yang EC, Desouza L, Diehl G, Rodrigues MJ, Romaschin AD, Colgan TJ, Siu KW. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics 5: 1953-1966, 2005.
14. Gyenge CC, Tenstad O, Wiig H. In vivo determination of steric and electrostatic exclusion of albumin in rat skin and skeletal muscle. J Physiol 552: 907-916, 2003.
15. Hamilton RG. Human IgG subclass measurements in the clinical laboratory. Clin Chem 33: 1707-1725, 1987.
16. Haslene-Hox H, Oveiand E, Berg KC, Kolmannskog O, Woie K, Saivcsen HB, Tenstad O, Wiig H. A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PLoS One 6: e19217, 2011.
17. Haslene-Hox H, Oveiand E, Woie K, Salvesen HB, Wiig H, Tenstad O. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue. Biochim Biophys Acta 1834: 2347-2359, 2013.
18. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, Juhola M, Tammi R, Tammi M, Kosma VM. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 62: 6410-6413, 2002.
19. Jain RK. The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 4: 1-23, 1997.
20. Kerr MA. The structure and function of human IgA. Biochem J 271: 285-296, 1990.
21. Krol A, Maresca J, Dewhirst MW, Yuan F. Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. Cancer Res 59: 4136-4141, 1999.
22. Laurent TC. The interaction between polysaccharides and other macromolecules. The exclusion of molecules from hyaluronic acid gels and solutions. Biochem J 93: 106-112, 1964.
23. Malamud D, Drysdale JW. Isoelectric points of proteins: a table. Anal Biochem 86: 620-647, 1978.
24. Monteiro RC, Halbwachs-Mecarelii L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28: 666-671, 1985.
25. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60: 2497-2503, 2000.
26. Norden AG, Iapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, Thakker RV, llnwin RJ, Wrong O. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60: 1885- 1892, 2001.
27. O'Connor SW, Bale WF. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res 44: 3719-3723, 1984.
28. Oien AH, Justad SR, Tenstad O, Wiig H. Effects of hydration on steric and electric charge-induced interstitial volume exclusion-a model. Biophys J 105: 1276-1284, 2013.
29. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 98: 193-202, 2005.
30. Pan S, Wang R, Zhou X, Corvera J, Kloc M, Sifers R, Gailick GE, Lin SH, Kuang J. Extracellular Alix regulates integrin-mediated cell adhesions and extracellular matrix assembly. EMBO J 27: 2077-2090, 2008.
31. Panned R, Johnson D, Travis J. Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry 13: 5439-5445, 1974.
32. Pham TV, Piersma SR, Oudgcnocg G, Jimenez CR. Label-free mass spectrometry-based proteomics for biomarker discovery and validation. Expert Rev Mol Diagn 12: 343-359, 2012.
33. Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1: 1-48, 2007.
34. Postawski K, Rechbergcr T, Skorupski P, Jakowicki JA. Extracellular matrix remodelling within the normal human ovarian capsule. Eur J Ohstet Gynecol Reprod Biol 67: 173-177, 1996.
35. Rolny C, Mazzone M, Tugucs S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Kncvcls E, Costa S, Vinckier S, Dresseiacr T, Akerud P, Dc Mol M, Saioniaki H, Phillipson M, Wyns S, Larsson E, Buysschaert I, Botling J, Hininielreich U, Van Ginderachter JA, Dc Palma M, Dewerchin M, Clacsson-Wcish L, Carmelict P. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PIGF. Cancer Cell 19: 31-44, 2011.
36. Rosen A, Ek K, Anian P. Agarose isoelectric focusing of native human immunoglobulin M and alpha 2-macroglobulin. J Immunol Methods 28: 1- 11, 1979.
37. Sagstad S, Oveiand E, Karlsen TV, Haslene-Hox H, Tenstad O, Wiig H. Age-related changes in rat dermal extracellular matrix composition affect the distribution of plasma proteins as a function of size and charge. Am J Physiol Heart Circ Physiol. In press.
38. Saiama I, Malone PS, Miliaimecd F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364, 2008.
39. Schwick HG, Haupt II. Purified human plasma proteins of unknown function. Jpn J Med Sci Biol 34: 299-327, 1981.
40. Sottrup-Jensen L, Stepanik TM, Kristcnsen T, Wierzbicki DM, Jones CM, Lonbiad PB, Magnusson S, Petersen TE. Primary structure of human alpha 2-macroglobulin. V. The complete structure. J Biol Chem 259: 8318-8327, 1984.
41. Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Ada 372: 33-42, 2006.
42. Stewart JJ, White JT, Yan X, Collins S, Dreschcr CW, Urban ND, Hood L, Lin B. Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5: 433-443, 2006.
43. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528-539, 2004.
44. Travis J, Garner D, Bowen J. Human alpha-1-antichymotrypsin: purification and properties. Biochemistry 17: 5647-5651, 1978.
45. Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS, MoMaTec Study G, Vandenput I, Aniant F, Akslen LA, Salvesen HB. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer. Clin Cancer Res 17: 3368-3377, 2011.
46. Voisin SN, Krakovska O, Matta A, DcSouza LV, Romaschin AD, Colgan TJ, Siu KW. Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One 6: e16352, 2011.
47. Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, Chen JK, Lin YJ, Chang PY, Wang CJ, Chao AS, Chang SD, Chang TC, Lai CH, Wang HS. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics 9: 1873-1884,2010.
48. Wiig H, Aukland K, Tenstad O. Isolation of interstitial fluid from rat mammary tumors by a centrifugation method. Am J Physiol Heart Circ Physiol 284: H416-H424, 2003.
49. Wiig H, Gyenge CC, Tenstad O. The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components. J Physiol 567: 557-567, 2005.
50. Wiig H, Kolmannskog O, Tenstad O, Bert JL. Effect of charge on interstitial distribution of albumin in rat dermis in vitro. J Physiol 550: 505-514, 2003.
51. Wiig H, Swartz MA. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92: 1005-1060. 2012.
52. Wocssner JK. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93: 440-147, 1961.